ProMetic Life Sciences Inc. (PLI.TO) said Tuesday that it received a $4.6 million purchase order from Octapharma under the onging supply agreement between ProMetric and Octapharma.
Octapharma is a Swiss based, independent global plasma fractionation company that specializes in human proteins.
Shipments to Octapharma in relation to this order are expected to exceed $2.0 million during the second half of 2012.
For comments and feedback: editorial@rttnews.com